For 20 years, brand-name CELEBREX has been prescribed to more than 35 million patients. If you have osteoarthritis or rheumatoid arthritis pain, ask your doctor about moving forward with brand-name CELEBREX.
Celebrex is clinically proven
CELEBREX is proven to significantly reduce joint pain compared to sugar pill*
CELEBREX demonstrated significant reduction in joint tenderness/pain and joint swelling compared to sugar pill*
Single doses of CELEBREX provided relief within 60 minutes†
Effectiveness of CELEBREX was shown to be similar to that of naproxen 500 mg twice daily.
Individual results may vary.
CARDIOVASCULAR SAFETY STUDY
CELEBREX PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE TAKING CELEBREX
100-200 MG 2 TIMES A DAY
- Did not show an increased risk of having a stroke, heart attack, or dying from a cardiovascular cause compared with patients taking ibuprofen 600-800 mg (3 times a day) or naproxen 375-500 mg (2 times a day)‡
- In a substudy of 444 patients, CELEBREX showed a decrease in mean blood pressure compared to patients taking ibuprofen 600-800 mg (3 times a day),‡ or patients taking naproxen 375-500 mg (2 times a day)§
‡This is statistically significant.
§Comparison not statistically significant.
CARDIOVASCULAR SAFETY STUDY DESIGN:
This was a double-blind, triple-dummy, multicenter, parallel group,
CARDIOVASCULAR SAFETY SUBSTUDY DESIGN:
In a substudy of 444 patients with osteoarthritis or rheumatoid arthritis and evidence of or at increased risk for coronary artery disease. The primary endpoint was the change from baseline in 24 hour mean systolic blood pressure at month 4.
Celebrex is the brand you recognize
The CELEBREX pill has a distinctive shape and marking to let you know you're getting the brand-name medication—pill to pill, month to month
If your pill does not say 7767 and you want brand-name CELEBREX, talk to your pharmacist
Celebrex Offers Savings To Patients
If eligible, patients may pay as little as $4 for each 30-day fill of brand-name CELEBREX—and could save up to $2,800 a year.*